Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4663313 | 0.76 | GSK3A (0.55) | GAADAOALDH1A1LMNAMAPT | |
| SCHEMBL6481556 | 0.72 | — | — | |
| SCHEMBL8536193 | 0.69 | — | — | |
| SCHEMBL6779927 | 0.68 | MGLL (0.50) | HSP90AA1GAAALDH1A1MAPTHTT | |
| SCHEMBL179104 | 0.68 | — | — | |
| SCHEMBL24300568 | 0.67 | MGLL (0.48) | HSP90AA1SMN1; SMN2NPSR1ALDH1A1LMNA | |
| SCHEMBL2905468 | 0.67 | MGLL (0.53) | HSP90AA1SMN1; SMN2NPSR1ALDH1A1LMNA | |
| SCHEMBL23132249 | 0.67 | ALDH1A1 (0.32) | CA1CA2ALDH1A1 | |
| SCHEMBL19014599 | 0.67 | MGLL (0.47) | HSP90AA1CCR6CA1CA2SMN1; SMN2 | |
| SCHEMBL8352726 | 0.66 | CA1 (0.40) | CA1CA2MAPTRAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127498-A1 | ANTI-FCRN ANTIBODIES | UCB BIOPHARMA SPRL (BE) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127498-A1 | ANTI-FCRN ANTIBODIES | FCGRT, FCGR1A, FCGR2A | HSP90AA1 3408/4885CCR6 2226/4885CA1 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.